In recent years, numerous studies have tested the relevance of neural oscillations in
neuropsychiatric conditions, highlighting the potential role of changes in temporal …

Abnormal γ band activity is observed in patients with schizophrenia and disease models in
animals, and is suggested to underlie the psychosis and cognitive/perceptual deficits …

The profound changes in perception and cognition induced by psychedelic drugs are
thought to act on several levels, including increased glutamatergic activity, altered functional …

Hypofunctioning of the N-methyl-D-aspartate receptor (NMDA-R) has been prominently
implicated in the pathophysiology of schizophrenia (ScZ). The current study tested the …

Selective serotonin reuptake inhibitors (SSRIs) are the primary pharmacological treatment
for depression, but SSRIs are effective in only half of the patients and typically take several …

New antidepressant pharmacotherapies that provide rapid relief of depressive symptoms
are needed. The NMDA receptor antagonist ketamine exerts rapid antidepressant actions in …

Recently, the N-methyl-d-aspartate-receptor (NMDAR) antagonist ketamine has emerged as
a fast-onset mechanism to achieve antidepressant activity, whereas its psychomimetic …

Distinct frequency bands can be differentiated from neuronal ensemble recordings, such as
local field potentials or electrocorticogram recordings. Recent years have witnessed a rapid …

Neuroanatomical, electrophysiological and behavioural abnormalities following timed
prenatal methylazoxymethanol acetate (MAM) treatment in rats model changes observed in …

The drug ketamine has been extensively studied due to its use in anaesthesia, as a model of
psychosis and, most recently, its antidepressant properties. Understanding the physiology of …